Viewing Study NCT06846320


Ignite Creation Date: 2025-12-25 @ 4:26 AM
Ignite Modification Date: 2026-01-16 @ 2:14 PM
Study NCT ID: NCT06846320
Status: RECRUITING
Last Update Posted: 2025-12-23
First Post: 2025-02-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Generalized Anxiety Disorder (GAD) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None LEGATO - (GAD) View
None Generalized Anxiety Disorder (GAD) View
None ABBV-932 View